The P2Y<sub>2</sub> receptor mediates the epithelial injury response and cell migration

American Journal of Physiology - Cell Physiology - Tập 299 Số 2 - Trang C411-C421 - 2010
Ilene Boucher1, Celeste B. Rich1, Albert Lee1, Meredith Marcincin1, Vickery Trinkaus‐Randall1,2
1Departments of 1Biochemistry and
2Ophthalmology, Boston University School of Medicine, Boston, Massachusetts

Tóm tắt

Injury to epithelial cells results in the release of ATP and stimulation of purinergic receptors and is thought to alter cell migration and wound repair. Medium from the injured cells triggers Ca2+ mobilization and phosphorylation of ERK, both of which are inhibited if the medium is pretreated with apyrase. To understand the wound repair mechanism that occurs with injury, our goal was to determine which purinergic receptor(s) was the critical player in the wound response. We hypothesize that the P2Y2 receptor is the key player in the response of corneal epithelial cells to cell damage and subsequent repair events. Cells transfected with short interfering RNA to either P2Y2 or P2Y4 were stimulated either by injury or addition of UTP and imaged using fluo 3-AM to monitor changes in fluorescence. When cells with downregulated P2Y2 receptors were injured or stimulated with UTP, the intensity of the Ca2+ release was reduced significantly. However, when cells with downregulated P2Y4 receptors were stimulated, only the UTP-induced Ca2+ response was reduced significantly. In addition, downregulation of the P2Y2 receptor inhibited wound closure compared with unstimulated cells or cells transfected with nontargeting sequence. This downregulation resulted also in an attenuation in phosphorylation of Src and ERK. Together, these data indicate that the P2Y2 receptor plays a major biological role in the corneal injury response and repair mechanisms.

Từ khóa


Tài liệu tham khảo

10.1254/jjp.78.113

10.1124/pr.58.3.3

10.1523/JNEUROSCI.5338-05.2006

10.1016/j.bbrc.2006.06.141

10.1146/annurev.bi.56.070187.001111

10.1128/MCB.20.23.9018-9027.2000

10.1152/ajpheart.01042.2002

10.1016/j.exer.2007.03.009

10.1016/S0028-3908(97)00125-1

10.1126/science.1132559

10.1126/science.1967852

10.1152/ajpcell.00271.2007

10.1042/bst0300011

10.1083/jcb.153.3.491

10.1167/iovs.02-0851

10.1385/MN:31:1-3:065

10.1152/ajpcell.00582.2001

10.1242/jcs.114.23.4185

10.1002/jcb.20258

10.1042/bj20031089

10.1074/jbc.M312230200

10.1167/iovs.08-1688

McGarrigle D, 2007, Sci Stke, 392, 35

10.1167/iovs.06-0209

10.1523/JNEUROSCI.19-11-04211.1999

10.1523/JNEUROSCI.23-06-02348.2003

10.1111/j.1475-1313.2004.00182.x

Ralevic V, 1998, Pharmacol Rev, 50, 413

10.1074/jbc.M801431200

10.1074/jbc.273.5.2653

10.1083/jcb.98.4.1565

10.1002/1097-4652(200009)184:3<385::AID-JCP14>3.0.CO;2-7

10.1111/j.1471-4159.2005.03408.x

10.1007/s11302-005-8132-6

10.1002/jcb.10774

10.1161/CIRCRESAHA.107.162271

10.1002/jcp.21248